Prevalence and Prescription of Antidepressants in Depression with Somatic Comorbidity in Asia: The Research on East Asian Psychotropic Prescription Patterns Study

Background: Depression is often comorbid with chronic somatic diseases. Few previous studies have investigated the prevalence of somatic diseases in depression or the prescription pattern of antidepressants in comorbidly depressed patients in Asia. This study aimed to investigate the prevalence of somatic comorbidity (SC) in depression and compared the prescriptions of antidepressants in depressed patients with and without SC. Methods: A total of 2320 patients treated with antidepressants in 8 Asian countries were examined, and a diagnosis was based on the International Classification of Disease, 10th revision. We listed 17 common chronic somatic diseases. Patients’ socio-demographic and clinical characteristics and psychotropic drug prescriptions were recorded using a standardized protocol and data collection procedure. Results: Of the patients examined, 1240 were diagnosed with depression and 30% of them (n = 375) had SC. The most common comorbid condition was diabetes (23.7%). The patients with SC were more likely to seek help at a general hospital (74.7% vs. 47.2%), and had a higher incidence of symptoms involving sadness, disturbed sleep, and poor appetite. Noradrenergic and specific serotonergic antidepressant was prescribed more for patients with SC than for those without SC (30.4% vs. 22.9%). Conclusions: SC is common in depressed Asian patients. It is important to strengthen the recognition of depression, especially in general hospitals and when patients report some somatic discomfort. It is also a matter of urgency to establish evidence-based guidelines for the use of new antidepressants in depressed patients with SC.

[1]  A. Clayton,et al.  Sexual dysfunction associated with major depressive disorder and antidepressant treatment , 2014, Expert opinion on drug safety.

[2]  Libo Zhao,et al.  Prevalence, correlates and recognition of depression in Chinese inpatients with cancer. , 2014, General hospital psychiatry.

[3]  C. Browning,et al.  Prevalence of depression in coronary heart disease in China: a systematic review and meta‐analysis , 2014, Chinese medical journal.

[4]  S. Kennedy,et al.  Treatment-Resistant Depression in Primary Care Across Canada , 2014, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[5]  J. Ruskin,et al.  Meta-analysis of selective serotonin reuptake inhibitor-associated QTc prolongation. , 2014, The Journal of clinical psychiatry.

[6]  Olga Hilas,et al.  Potential role of mirtazapine in underweight older adults. , 2014, The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists.

[7]  D. Miličić,et al.  Somatic comorbidity, metabolic syndrome, cardiovascular risk, and CRP in patients with recurrent depressive disorders , 2013, Croatian medical journal.

[8]  H. Möller,et al.  World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Update 2013 on the acute and continuation treatment of unipolar depressive disorders , 2013, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[9]  B. Penninx,et al.  The Impact of Chronic Somatic Diseases on the Course of Depressive and Anxiety Disorders , 2012, Psychotherapy and Psychosomatics.

[10]  Jens Knud Larsen Mirtazapine versus other antidepressive agents for depression , 2012, Ugeskrift for laeger.

[11]  Gert P. Westert,et al.  Current Guidelines Have Limited Applicability to Patients with Comorbid Conditions: A Systematic Analysis of Evidence-Based Guidelines , 2011, PloS one.

[12]  From Ora Staff Reports FDA Safety Alert: Abnormal heart rhythms associated with high doses of citalopram hydrobromide , 2011 .

[13]  B. Zhong,et al.  Prevalence, correlates and recognition of depression among inpatients of general hospitals in Wuhan, China. , 2010, General hospital psychiatry.

[14]  Qichang Shi,et al.  Prevalence, treatment, and associated disability of mental disorders in four provinces in China during 2001–05: an epidemiological survey , 2009, The Lancet.

[15]  W. Eaton,et al.  Depression and Type 2 Diabetes Over the Lifespan: A Meta-Analysis , 2009, Diabetes Care.

[16]  R. Kessler,et al.  Association of perceived stigma and mood and anxiety disorders: results from the World Mental Health Surveys , 2008, Acta psychiatrica Scandinavica.

[17]  M. Phillips,et al.  Prevalence and rates of recognition of depressive disorders in internal medicine outpatient departments of 23 general hospitals in Shenyang, China. , 2008, Journal of affective disorders.

[18]  L. Turhan,et al.  Mirtazapine improves sleep and lowers anxiety and depression in cancer patients: superiority over imipramine , 2008, Supportive Care in Cancer.

[19]  P. Groenewegen,et al.  The influence of specific chronic somatic conditions on the care for co-morbid depression in general practice , 2007, Psychological Medicine.

[20]  D. Rao,et al.  Culture, Somatization, and Psychological Distress: Symptom Presentation in South Indian Patients from a Public Psychiatric Hospital , 2007, Psychopathology.

[21]  H. V. van Hout,et al.  Depression and the risk for cardiovascular diseases: systematic review and meta analysis , 2007, International journal of geriatric psychiatry.

[22]  R. Baldessarini,et al.  Newer antidepressant drug use in East Asian psychiatric treatment settings: REAP (Research on East Asia Psychotropic Prescriptions) Study. , 2007, British journal of clinical pharmacology.

[23]  A. Rush STAR*D: what have we learned? , 2007, The American journal of psychiatry.

[24]  D. Steffens,et al.  A three‐factor analytic model of the MADRS in geriatric depression , 2003, International journal of geriatric psychiatry.

[25]  B. Mulsant,et al.  Post stroke depression: epidemiology, pathophysiology, and biological treatment , 2002, Biological Psychiatry.

[26]  K. Freedland,et al.  The prevalence of comorbid depression in adults with diabetes: a meta-analysis. , 2001, Diabetes care.

[27]  John E. Roberts,et al.  Meta-analysis of the relationship between HIV infection and risk for depressive disorders. , 2001, The American journal of psychiatry.

[28]  S. Patten,et al.  Long-term medical conditions and major depression in a Canadian population study at waves 1 and 2. , 2001, Journal of affective disorders.

[29]  C. Murray,et al.  Burden of disease--implications for future research. , 2001, JAMA.

[30]  R. Carney,et al.  Depression as a risk factor for cardiac events in established coronary heart disease: A review of possible mechanisms , 1995, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.

[31]  A. Stewart,et al.  The functioning and well-being of depressed patients. Results from the Medical Outcomes Study. , 1989, JAMA.

[32]  Xu Jiong-jion Choice of First-visit Modes of Patients with Depressive Disorders and Its Clinical Characteristics , 2012 .

[33]  K. Otani,et al.  A three‐factor model of the MADRS in major depressive disorder , 2005, Depression and anxiety.

[34]  Matthew J. Taylor,et al.  Strategies for managing sexual dysfunction induced by antidepressant medication. , 2004, The Cochrane database of systematic reviews.

[35]  I. Levav,et al.  The WHO World Health Report 2001 new understanding--new hope. , 2002, The Israel journal of psychiatry and related sciences.